| Hidradenitis Suppurativa |
1 |
1 |
| Biologic Therapy |
0 |
0.95 |
| Skin and Soft Tissue Infection |
0 |
0.9 |
| Quality of Life |
0 |
0.81 |
| Dentistry and Oral Health |
0 |
0.45 |
| Fungal Infection |
0 |
0.3 |
| Abscess |
0 |
0.27 |
| Europe |
0 |
0.27 |
| Germany |
0 |
0.27 |
| Monoclonal Antibody |
0 |
0.27 |
| Nodule |
0 |
0.27 |
| Oral Candidiasis |
0 |
0.27 |
| Adherence |
0 |
0.23 |
| Candidiasis |
0 |
0.21 |
| Board Certification |
0 |
0.13 |
| California |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Dermatoses |
0 |
0.13 |
| Immunopathogenesis |
0 |
0.13 |
| Interleukin |
0 |
0.13 |
| Shared Decision-Making |
0 |
0.13 |
| Tumor |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Psoriasis |
0 |
0.11 |